1. Home
  2. HBIO vs CDIO Comparison

HBIO vs CDIO Comparison

Compare HBIO & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBIO
  • CDIO
  • Stock Information
  • Founded
  • HBIO 1901
  • CDIO 2017
  • Country
  • HBIO United States
  • CDIO United States
  • Employees
  • HBIO N/A
  • CDIO N/A
  • Industry
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • HBIO Industrials
  • CDIO Health Care
  • Exchange
  • HBIO Nasdaq
  • CDIO Nasdaq
  • Market Cap
  • HBIO 16.9M
  • CDIO 19.5M
  • IPO Year
  • HBIO 2000
  • CDIO N/A
  • Fundamental
  • Price
  • HBIO $0.40
  • CDIO $0.46
  • Analyst Decision
  • HBIO Buy
  • CDIO Buy
  • Analyst Count
  • HBIO 2
  • CDIO 1
  • Target Price
  • HBIO $4.50
  • CDIO $2.00
  • AVG Volume (30 Days)
  • HBIO 349.2K
  • CDIO 763.1K
  • Earning Date
  • HBIO 05-06-2025
  • CDIO 05-14-2025
  • Dividend Yield
  • HBIO N/A
  • CDIO N/A
  • EPS Growth
  • HBIO N/A
  • CDIO N/A
  • EPS
  • HBIO N/A
  • CDIO N/A
  • Revenue
  • HBIO $94,135,000.00
  • CDIO $34,890.00
  • Revenue This Year
  • HBIO N/A
  • CDIO $1,434.82
  • Revenue Next Year
  • HBIO $8.58
  • CDIO $4,661.91
  • P/E Ratio
  • HBIO N/A
  • CDIO N/A
  • Revenue Growth
  • HBIO N/A
  • CDIO 104.45
  • 52 Week Low
  • HBIO $0.36
  • CDIO $0.19
  • 52 Week High
  • HBIO $4.08
  • CDIO $1.77
  • Technical
  • Relative Strength Index (RSI)
  • HBIO 35.65
  • CDIO 58.99
  • Support Level
  • HBIO $0.56
  • CDIO $0.30
  • Resistance Level
  • HBIO $0.45
  • CDIO $0.43
  • Average True Range (ATR)
  • HBIO 0.06
  • CDIO 0.05
  • MACD
  • HBIO 0.02
  • CDIO 0.01
  • Stochastic Oscillator
  • HBIO 28.71
  • CDIO 93.41

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Share on Social Networks: